TLR Crosstalk Activates LRP1 to Recruit Rab8a and PI3Kγ for Suppression of Inflammatory Responses
Lin Luo,
Adam A. Wall,
Samuel J. Tong,
Yu Hung,
Zhijian Xiao,
Abdullah A. Tarique,
Peter D. Sly,
Emmanuelle Fantino,
María-Paz Marzolo,
Jennifer L. Stow
Affiliations
Lin Luo
Institute for Molecular Bioscience (IMB) and IMB Centre for Inflammation and Disease Research, The University of Queensland, Brisbane, QLD 4072, Australia
Adam A. Wall
Institute for Molecular Bioscience (IMB) and IMB Centre for Inflammation and Disease Research, The University of Queensland, Brisbane, QLD 4072, Australia
Samuel J. Tong
Institute for Molecular Bioscience (IMB) and IMB Centre for Inflammation and Disease Research, The University of Queensland, Brisbane, QLD 4072, Australia
Yu Hung
Institute for Molecular Bioscience (IMB) and IMB Centre for Inflammation and Disease Research, The University of Queensland, Brisbane, QLD 4072, Australia
Zhijian Xiao
Institute for Molecular Bioscience (IMB) and IMB Centre for Inflammation and Disease Research, The University of Queensland, Brisbane, QLD 4072, Australia
Abdullah A. Tarique
Child Health Research Centre, The University of Queensland, Brisbane, QLD, Australia
Peter D. Sly
Child Health Research Centre, The University of Queensland, Brisbane, QLD, Australia
Emmanuelle Fantino
Child Health Research Centre, The University of Queensland, Brisbane, QLD, Australia
María-Paz Marzolo
Laboratorio de Tráfico Intracelular y Señalización, Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica, Santiago, Chile
Jennifer L. Stow
Institute for Molecular Bioscience (IMB) and IMB Centre for Inflammation and Disease Research, The University of Queensland, Brisbane, QLD 4072, Australia; Corresponding author
Summary: The multi-ligand endocytic receptor, low-density lipoprotein-receptor-related protein 1 (LRP1), has anti-inflammatory roles in disease. Here, we reveal that pathogen-activated Toll-like receptors (TLRs) activate LRP1 in human and mouse primary macrophages, resulting in phosphorylation of LRP1 at Y4507. In turn, this allows LRP1 to activate and recruit the guanosine triphosphatase (GTPase), Rab8a, with p110γ/p101 as its phosphatidylinositol 3-kinase (PI3K) effector complex. PI3Kγ is a known regulator of TLR signaling and macrophage reprogramming. LRP1 coincides with Rab8a at signaling sites on macropinosomal membranes. In LRP1-deficient cells, TLR-induced Rab8 activation is abolished. CRISPR-mediated knockout of LRP1 in macrophages alters Akt/mTOR signaling and produces a pro-inflammatory bias in cytokine outputs, mimicking the Rab8a knockout and PI3Kγ-null phenotype. Thus, TLR-LRP1 crosstalk activates the Rab8a/PI3Kγ complex for reprogramming macrophages, revealing this as a key mechanism through which LRP1 helps to suppress inflammation. : Luo et al. show that the multifunctional endocytic receptor, LRP1, is crosstalk activated by agonist-activated TLRs on macrophages. Phosphorylated LRP1 recruits a Rab/PI3K complex that activates Akt/mTOR signaling to repolarize macrophages and bias inflammatory cytokine outputs. Through this mechanism, LRP1 helps to suppress TLR-induced inflammation. Keywords: LRP1, Rab8a, PI3Kγ, inflammation, Toll-like receptor, Akt, mTOR, crosstalk, macrophage, polarization